Pharma

Community Corner

In an effort to foster the highest level of transparency between pharmaceutical companies and the AS community, FAST welcomes and hosts a robust channel of communication for our partners. All such news is archived here for public access.

Angelman Syndrome News

Good Morning, Gus

CAN Spotlight: Hole Out Fore Heath

FAST announces new board chair, Ryan Jacob

Ryan Jacob Assumes Board Chair Role At Foundation for Angelman Syndrome Therapeutics

2023 Cure Angelman Now (CAN) Fundraising Recap

CAN Spotlight: Remi Cup

UNC Brain Development Study of Infants with AS

Ultragenyx Pharmaceutical provides AS Development Pipeline Updates

Recruitment Open for Roche Aldebaran Study

New FAST-funded Study on Brain-Derived Neurotrophic Factor Activity

New FAST and ABOM Study Focuses on Motor Function as a Critical Aspect of Angelman Syndrome

NIH Announces Large Grant for Gene Editing Platform to Yale University, Foundation for Angelman Syndrom...

New publication supported by FAST and ABOM about the Vineland Adaptive Behavior Scales

Welcome, FAST Poland

Good Morning, Gus

CAN Spotlight: Hole Out Fore Heath

FAST announces new board chair, Ryan Jacob

Ryan Jacob Assumes Board Chair Role At Foundation for Angelman Syndrome Therapeutics

2023 Cure Angelman Now (CAN) Fundraising Recap

CAN Spotlight: Remi Cup

UNC Brain Development Study of Infants with AS

Ultragenyx Pharmaceutical provides AS Development Pipeline Updates

Recruitment Open for Roche Aldebaran Study

New FAST-funded Study on Brain-Derived Neurotrophic Factor Activity

New FAST and ABOM Study Focuses on Motor Function as a Critical Aspect of Angelman Syndrome

NIH Announces Large Grant for Gene Editing Platform to Yale University, Foundation for Angelman Syndrom...

New publication supported by FAST and ABOM about the Vineland Adaptive Behavior Scales

Welcome, FAST Poland